2023 annual financial data
Kura Oncology 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -165,804,000 USD and net income was -152,631,000 USD.
Operating cash flow was -124,824,000 USD.
Get free Kura Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -165,804,000 USD
- Net income
- -152,631,000 USD
- Operating cash flow
- -124,824,000 USD